You are currently using an unsupported browser which could affect the appearance and functionality of this website. Please consider upgrading to the latest version or using alternatives such as Mozilla Firefox, Google Chrome or Microsoft Edge.

Morcellation for myomectomy or hysterectomy (Consent Advice No. 13)

Summary

This paper provides advice for healthcare professionals obtaining consent from women undergoing morcellation for myomectomy or hysterectomy. After discussion with the woman, the consent form should be carefully edited under the heading ‘Name of proposed procedure or course of treatment’ to accurately describe the exact procedure to be performed.

The paper follows the structure of Consent Form 1 from the Department of Health and Social Care, England/Welsh Assembly Government/Department of Health, Northern Ireland. It should be used in conjunction with the RCOG Clinical Governance Advice No. 6 Obtaining Valid Consent and Clinical Governance Advice No. 7 Presenting Information on Risk.

The aim of this advice is to ensure that all women are given consistent and adequate information for consent. It is intended for use together with dedicated patient information. At discharge, women should be provided with clear direction to enable them to obtain help if there are unforeseen problems after discharge.

This Consent Advice and the accompanying patient information leaflet were developed by a specialist Morcellation Task and Finish Group, details for which are available on request. These documents were reviewed by members of the RCOG Women’s Network and Women’s Voices Involvement Panel and by women and their families across the UK with close experience of this procedure.


Please note

This consent advice document should be used as part of the process outlined on our main consent page. The form should be used to help record women’s understanding of the implications of the final agreed procedure and should be used alongside the accompanying RCOG patient information leaflet Information for you: Morcellation for myomectomy or hysterectomy.


COVID disclaimer

This Consent Advice was developed prior to the emergence of the COVID-19 coronavirus.

Version history

This is the first edition of this guidance.

Please note that the Patient Safety Committee regularly assesses the need to update. Further information on this review is available on request.

Developer declaration of interests

Available on request.

This page was last reviewed 10 October 2019.